Posted in | News | Bionanotechnology

New On-Site DNA Authentication Program for Cotton Textiles from Applied DNA Sciences

Applied DNA Sciences, Inc., a provider of DNA-based anti-counterfeiting technology, supply chain and product authentication solutions, announced today the launch of an On-Site DNA Authentication Program (On-Site) in response to the market need to provide faster reporting of DNA authentication at every step of the cotton textile supply chain, with the goal of ensuring quality assurance, controls and sourcing of raw materials or greige goods, prior to conversion into finished goods.

The patent-pending, On-Site Program includes the provision of a desktop-size PCR (Polymerase Chain Reaction) machine with consumables for testing, complete with supporting software, on-site training, guidance on chain-of-custody protocols, and online customer service support. APDN will consult with its licensees and its supply chain partners to ensure seamless program implementation.

Potential licensees will benefit from the program by having the On-Site device located at their facility, with the ability to test a large volume of samples from different lots or batches, of raw fiber, yarn or fabric, before they are converted into finished goods. As part of the program, APDN will receive retain samples from Licensees to enable full forensic evaluation and authentication whenever required.

Dr. Mike Hogan, VP of Life Sciences, stated, "We are very excited to offer this turn-key solution that allows for both fiberTyping® and SigNature® T authentication of greige goods on site. Higher volume of testing translates to a higher degree of confidence in the authenticity of the source material."

This program will enable the on-site testing of unprocessed fiber, yarn or fabric (greige goods) by anyone in the cotton textile supply chain, including growers, ginners, spinners, manufacturers, logistics partners, brand owners, retailers and government agencies. Forensic authentication of the relevant DNA on site will help ensure that companies are compliant with international or in-country label laws.

The On-Site DNA Authentication platform complements the company's multi-modal screening platform that was announced last week. The former provides DNA-based proof of origin or authenticity, while the latter enables rapid screening with higher level of assurances than any visual inspection. The On-Site DNA Authentication Platform will be integrated with the company's service platform for full forensic assessment of its DNA markers, including Certificates of DNA Authentication (CODAs) and expert witnessing for court cases.

Dr. James Hayward, President and CEO of APDN, commented: "This is a development of historic importance, as we believe we are the first and only company to place forensic authentication in the hands of our customers and partners. If I were a brand owner, I would want to ensure that my products are never compromised. The transparency this program offers will allow brand owners, in collaboration with the textile manufacturers and suppliers, to deliver on their promise to the consumer with confidence."

The company expects to roll out on-site DNA authentication systematically to other industry verticals, including Cash and Valuables in Transit (CViT), pharmaceutics, print media, industrial materials and others.

Source: http://www.adnas.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.